a randomized phase iii study was carried out in 57 patients with metastatic melanoma treated with either dacarbazine ( dtic ) given intravenously ( iv ) daily for 10 days using light protection , or a combination of vinblastine iv on days 1 and 2 , bleomycin by continuous iv infusion during days 1-5 , and cisplatin by iv infusion on day 5 ( vbd ) .
C0042670
vinblastine
C0072634
vbd